Pfizer's Chantrix anti-smoking pill banned on Side Effects Study
Anti-Smoking pill Chantrix from Pfizer Inc. was banned today by the Federal Aviation Administration for its use by pilots and air traffic controlers, after a study showed dangerous side effects.
Chantrix was related to more than 3,000 reports in the United states regarding side effects such as dizziness, loss of consciousness, seizures, abnormal spams, heart trouble, aggression and even suicide, the Institute for Safe Medication Practices reported.
"Often these reports lack sufficient medical information and/or have confounding factors that prevent a meaningful assessment of causality." said Pfizer in a statement.
Through a study, the non-profit institute delivered its results to the Food and Drug Administration and urged the health regulators to tighten warnings of the drug.
The company stated that the product's label warns about driving or operating machinery.
So far, the FAA hasn't reported any aviation accident related to Chantrix.
Shares of Pfizer fell 1.05 percent to $19.80 in after hours electronic trading of the New York Stock Exchange on Wednesday.
- 1 China to launch stock exchange for smaller companies
- 2 Obama bringing hefty agenda on European trip
- 3 GM sees bankruptcy risk
- 4 For Wall Street, March is best month since 2002
- 5 North Korea missile consistent with satellite: U.S.
- 6 HK, Shenzhen agree on innovation plan
- 7 $6.6b Gov't deficit recorded
- 1 Microsoft's Bing makes early gains: study
- 2 Fiat to stay course on Chrysler despite court delay
- 3 Fiat won't walk away from Chrysler deal: spokesman
- 4 Three groups have entered bids for GM's Saab: report
- 5 Oil rises towards $69 as dollar dips and ahead of stocks data
- 6 Texas Instruments raises quarterly targets
- 7 Tech cos enlist Democrat to blast Obama tax plan
|
|
